Concentration of procalcitonin and C-reactive protein in serum and erythrocyte sedimentation rate in active autoimmune diseases in children;Prokalcytonina, białko C-reaktywne i odczyn opadania krwinek czerwonych w aktywnej fazie chorób autoimmunizacyjnych u dzieci

Polski Merkuriusz Lekarski

Volumn 15, Issue 86, 2003, Pages 155-157

  Korczowski, Bartosz ^a,c   Kowalczyk, Jerzy R ^b   Bijak, Małgorzata ^a   Rusin, Józef ^a  

^a Szpital Wojewodzki nr 2 ^*  (Poland)

^b Klinika Hematologii i Onkologii   (Poland)

^c Oddzial Dzieciecy Szpitala   (Poland)

Author keywords

Autoimmune disease; C reactive protein; Erythrocyte sedimentation rate; Procalcitonin

Indexed keywords

C REACTIVE PROTEIN; CALCITONIN; PROCALCITONIN; PROTEIN PRECURSOR;

ADOLESCENT; ARTICLE; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; BEHCET DISEASE; BLOOD; CHILD; CLINICAL ARTICLE; CROHN DISEASE; DERMATOMYOSITIS; DISEASE COURSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMOLYTIC ANEMIA; HUMAN; IMMUNOASSAY; INFANT; JUVENILE RHEUMATOID ARTHRITIS; MALE; METABOLISM; PRESCHOOL CHILD; PRIMARY SCLEROSING CHOLANGITIS; PROTEIN BLOOD LEVEL; SCLERODERMA; SERUM; SYSTEMIC LUPUS ERYTHEMATOSUS; TURBIDIMETRY; ULCERATIVE COLITIS;

ADOLESCENT; AUTOIMMUNE DISEASES; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CALCITONIN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; PROTEIN PRECURSORS;

EID: 0141425645     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Al.-Nawas B., Krammer I., Shah P.M.: Procalcitonin in diagnosis of severe infections. Eur. J. Med. Res., 1995/96, 1, 7, 331-3.
2. Al.-Nawas B., Shah P.M.: Procalcitonin in patients with and without immunosuppression and sepsis. Infection, 1996, 26, 6, 434-6.
3. Assicot M. i wsp.: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet, 1993, 341, 8844, 515-18.
4. Braithwaite S.: Procalcitonin: new insights on regulation and origin. Crit. Care Med., 2000, 28, 2, 586-8.
5. Campbell C.A. i wsp.: Acute phase proteins in chronic inflammatory bowel disease in childhood. J. Pediatr. Gastroenterol. Nutr., 1982, 1, 2, 193-200.
6. Carsin H. i wsp.: Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF-α and endotoxin levels early after thermal injury. Burns, 1997, 23, 3, 218-24.
7. Chiesa C. i wsp.: Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin. Infect. Dis., 1998, 26, 3, 664-72.
8. Dandona P. i wsp.: Procalcitonin increase after endotoxin injection in normal subjects. J Clin. Endocrinol. Metabol., 1994, 79, 5, 1605-8.
9. Davis T. i wsp.: Serum procalcitonin concentrations in acute malaria. Trans. R. Soc. Trop. Med. Hyg., 1994, 88, 6, 670-1.
10. de Werra I. i wsp.: Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit. Care. Med., 1997, 25, 4, 607-13.
11. Eberhard O.K. i wsp.: Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis & Rheumatism, 1997, 40, 7, 1250-6.
12. Gendrel D. i wsp.: Procalcitonin as a marker for the early diagnosis of neonatal infection. J. Pediatr., 1996, 128, 4, 570-3.
13. Gendrel D. i wsp.: Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin. Infect. Dis., 1997, 24, 6, 1240-2.
14. Gerard Y. i wsp.: Procalcitonin as a marker of bacterial sepsis in patient infected with HIV-1. J. Infect., 1997, 35, 41-6.
15. Gervaix A. i wsp.: Usefulness of procalcitonin and C-reactive protein rapid tests for the management of children with urinary tract infection. Pediatr. Infect. Dis. J., 2001, 20, 5, 507-11.
16. Hatherill M. i wsp.: Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leukocyte count. Arch. Dis. Child., 1999, 81, 5, 417-21.
17. Kettelhack C. i wsp.: Induction of systemic serum procalcitonin and cardiocirculatory reactions after isolated limb perfusion with recombinant human tumor necrosis factor-a and melphalan. Crit. Care. Med., 2000, 28, 4, 1040-6.
18. Kretzschmar M., Krüger A., Schirrmeister.: Procalcitonin following elective partial liver resection - origin from the liver? Acta Anest. Scand., 2001, 45, 1162-7.
19. Kuse E.R. i wsp.: Procalcitonin in fever of unknown origin after liver transplantation: a variable to differentiate acute rejection from infection. Crit. Care Med., 2000, 28, 2, 555-9.
20. Level C., Chauveau P., Delmas Y.: Procalcitonin: a new marker of inflammation in haemodialysis patients. Nephrol. Dial. Transplant., 2001, 16, 980-6.
21. Mangge H. i wsp.: Serum cytokines in juvenile rheumatoid arthritis. Arthritis Rheum., 1995, 38, 211-20.
22. Martinez-Cordero E., Orozco Barocio G., Martinez Miranda E.: Evaluation of disease activity by laboratory tests in juvenile rheumatoid arthritis. J. Invest. Allergol. Clin. Immunol., 1995, 5, 4, 216-20.
23. Mimoz O. i wsp.: Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intens. Care Med., 1998, 24, 185-8.
24. Monneret G., Laroche B., Bienvenu J.: Procalcitonin is not produced by circulating blood cells. Infection, 1999, 27, 1, 34-35.
25. Nijsten M.W. i wsp.: Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit. Care Med., 2000, 28, 2, 458-61.
26. Nylen E.S. i wsp.: Pneumonitis associated hyperprocalcitoninemia. Am. J. Med. Sci., 1996, 312, 1, 12-18.
27. Nylen E.S. i wsp.: Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit. Care. Med., 1998, 26, 6, 1001-6.
28. Oberhoffer M. i wsp.: Outcome prediction by traditional and new markers of inflammation in patients with sepsis. Clin. Chem. Lab. Med., 1999, 37, 3, 363-8.
29. Rau B. i wsp.: The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut, 1997, 41, 832-40.
30. Redl H. i wsp.: Procalcitonin release patterns in a baboon model of trauma and sepsis: Relationship to cytokines and neopterin. Crit. Care Med., 2000, 28, 11, 3659-63.
31. Reith H.B. i wsp.: Procalcitonin in early detection of postoperative complications. Dig. Surg., 1998, 15, 3, 260-5.
32. Sabat R. i wsp.: Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies. Intensive Care Med., 2001, 27, 987-991.
33. Schwenger V. i wsp.: CRP levels in autoimmune disease can be specified by measurement of procalcitonin. Infection, 1998, 26, 5, 274-6.
34. Shin K.C. i wsp.: Serum Procalcitonin measurement for detection of intercurrent infection in febrile patients with SLE. Ann. Rheum., 2001, 60, 10, 988-9.
35. Staehler M. i wsp.: Procalcitonin: a new marker for differential diagnosis of acute rejection and bacterial infection in heart transplantation. Transplant. Proc., 1997, 29, 584-5.